October 22nd, 2010
Podcast 105: NSAIDs revisited
In the face of scheduling problems we’ve had to postpone this week’s interview and use, instead, one from early this summer. It’s on NSAIDs, and if you missed it, it’s worth a listen. If you didn’t miss it, then join us again next week, but give a listen to the news round-up before you head […]
March 27th, 2010
Podcast 80: Bisphosphonates and atypical hip fractures — how large is the risk?
We talk with three of the academic authors of a New England Journal of Medicine study that pooled data from a few studies in an attempt to examine the possible link between use of bisphosphonates and femoral-shaft fractures. Interview-related links: Physician’s First Watch coverage NEJM paper NEJM editorial FDA statement News-related links: Aspirin ineffective in preventing miscarriage BNP-guided […]
July 2nd, 2009
Podcast 48: A conversation with Les Irwig, which your bone scanner won’t like to hear.
Scanning patients on bisphosphonates within the first 3 years of therapy is just wasted effort, and may even be misleading clinically. That’s what researchers conclude after reanalysis of FIT trial data on some 6500 women taking either alendronate or placebo. Prof. Les Irwig of the University of Sydney talks about his team’s findings and what […]
June 29th, 2009
Podcast 47: Total knee arthroplasty’s cost-effectiveness — a conversation with Elena Losina
Who knew that discussing QALYs could be so enjoyable? Dr. Elena Losina guides the interviewer through the thicket of cost-effectiveness and points to resources that keep track of the cost-effectiveness of most procedures. This is all done in the context of discussing her paper in Archives of Internal Medicine on total knee arthroplasty. This week’s […]
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
